n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, October 19th, 2015

The QualityStocks
Daily Stock List

graphic
graphic

The Grilled Cheese Truck, Inc. (GRLD)

Today we choose to report on The Grilled Cheese Truck, Inc. (GRLD) here at the QualityStocks Daily Newsletter.

The Grilled Cheese Truck, Inc. operates and licenses grilled cheese food trucks in the Los Angeles, Tacoma and Phoenix areas. In addition, the Company is rolling out into additional markets with the aim of becoming the largest operator in the gourmet food truck space. Its strategy includes The Grilled Cheese Truck offerings at stadiums, military bases, universities, casinos and related venues, festivals, motorsports, action sports, team sports, large outdoor events/concerts, large churches and schools.

The Grilled Cheese Truck lists on the OTC Markets’ OTCQB. The Company has its headquarters in Fort Lauderdale, Florida. It incorporated on December 31, 2009 and became a public company on August 5, 2010.

The Company is working to franchise its Gourmet Grilled Cheese Trucks operations. Its intention is to offer franchised grilled cheese trucks to Veterans, having invested considerable time and resources over the past two years to develop a business model that creates jobs, business opportunities and support for Veterans.

The Grilled Cheese Truck’s menu includes the Plain and Simple Melt (on French or Wheat Bread); Cheesy Mac; French Onion Soup Melt (on French Bread); and Brie Melt (on Cranberry Walnut Bread). It also includes Pepperbelly Melt (on French bread); Goat Cheese Melt (on Nine-Grain Bread), as well as Dessert Melts. Sides include Tomato Soup: Shot/Cup; Mac and Cheese: Cup; Tater Tots w/ Sea Salt; Homemade B&B Pickle Chips, and Daily Dipping Sauces.

This month, Soupman, Inc. (SOUP) announced that it received approval from New York State to go forward on a Master Franchise Agreement with The Grilled Cheese Truck to launch Original Soupman & The Grilled Cheese Truck mobile units across the country. The branded mobile units (which may be trucks or carts) will be targeted to be franchised to war veterans who wish to own and operate their own business in the growing gourmet mobile food cart/truck industry.

The Grilled Cheese Truck, Inc. (GRLD), closed Monday's trading session at $0.96, up 4.35%, on 25,960 volume with 21 trades. The average volume for the last 60 days is 33,378 and the stock's 52-week low/high is $0.518/$6.00.

Cortex Pharmaceuticals, Inc. (CORX)

TopPennyStockMovers, Wallstreetlivechat, and TheMicrocapNews reported earlier on Cortex Pharmaceuticals, Inc. (CORX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Founded in 1987, Cortex Pharmaceuticals, Inc. is a biopharmaceutical company currently involved in the discovery and development of drugs for the treatment of respiratory disorders. It has manifold drug development programs targeted towards the treatment of brain-related breathing disorders, including obstructive or central sleep apnea and drug-induced respiratory depression. Cortex Pharmaceuticals is headquartered in Glen Rock, New Jersey.

Drug candidates are presently derived from two platforms. One is a class of compounds called ampakines, which act as positive allosteric modulators of AMPA glutamate receptors. A number of ampakines in oral and injectable form are undergoing development by Cortex Pharmaceuticals for the treatment of drug induced respiratory depression caused by opiates and anesthetics.

In preclinical and clinical studies, such drugs have shown preliminary efficacy in central sleep apnea and restored normal respiration without altering the analgesic effects of opiates or the anesthetic effects of drugs such as propofol. The Company’s compounds belong to a new generation of ampakines that do not display the undesirable side effects displayed by earlier compounds.

The other platform is the class of compounds called cannabinoids, particularly, dronabinol. In a double-blind, placebo-controlled, dose-ascending Phase 2A clinical study conducted by Cortex, dronabinol considerably improved measures of sleep apnea in a group of patients with obstructive sleep apnea. A larger 120 patient, double-blind, placebo-controlled Phase 2B clinical study is now being conducted by the University of Illinois. It is being funded by the National Institutes of Health (NIH).

Cortex Pharmaceuticals owns patents and patent applications for certain families of chemical compounds, which claim the chemical structures and their use in the treatment of diverse disorders. These patents cover, among other compounds, Cortex’s lead ampakines CX1739 and CX1942 and extend through at least 2028.

At the end of August, Cortex Pharmaceuticals announced an initial closing of $721,180 under a private placement of up to $3 million of units at $0.02103 per unit. Cortex sold 34,292,917 units, consisting of one share of common stock and one warrant to purchase two additional shares of common stock.

The proceeds from the initial closing of the private placement are intended mainly to support its clinical trial program regarding the development of ampakines for the treatment of central sleep apnea and opiate induced respiratory depression, starting with a Phase 2A clinical study of CX1739, its lead ampakine, and also to fund corporate general and administrative costs.

Cortex Pharmaceuticals, Inc. (CORX), closed Monday's trading session at $0.0249, down 7.43%, on 24,898 volume with 9 trades. The average volume for the last 60 days is 167,701 and the stock's 52-week low/high is $0.015/$0.075.

Xenonics Holdings, Inc. (XNNH)

PennyStocks24, Bull Trends, Club Penny Stocks Network, PennyStockScholar, Stock Rich, Cool PennyStocks, BullRally, and Stockpalooza reported earlier on Xenonics Holdings, Inc. (XNNH), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

OTCQB-listed Xenonics Holdings, Inc. develops and produces advanced, lightweight, and compact ultra-high-intensity illumination and low-light vision products. These products are for military, law enforcement, public safety, and also private sector and commercial applications. The Company utilizes patented technologies. Xenonics provides inventive solutions for customers who must see farther so they can do their jobs safer as well as better. Xenonics Holdings is headquartered in Carlsbad, California.

The Company’s illumination engine delivers tightly focused, ultra-high intensity beams of visible or infrared light (and also ultraviolet). Moreover, Xenonics’ technology produces a beam without the "black hole" that is characteristic of other illumination products.

Xenonics' NightHunter line of illumination products is used by every branch of the U.S. Armed Forces. This line is also used by law enforcement and security agencies. NightHunters provide unique capabilities that permit users to see first and act first, with the versatility to quickly adapt to and dominate changing conditions at night. The NightHunter line of products consists of the NightHunterONE, NightHunter3, and the NightHunterext.

The design of Xenonics’ SuperVision high-definition night vision is for commercial and military applications. SuperVision’s performance compares to military-grade (Gen III) night vision. It provides greater resolution, better clarity, and longer range and zoom capability.

SuperVision’s patented digital technology offers a 2x to 8x zoom magnification, high resolution HDTV display, and proprietary DSP technology. SuperVision is especially designed for military, law enforcement, and security professionals and their special requirements in the dangerous international environment. 

Xenonics Holdings announced in November 2014 that it was awarded a purchase order valued in excess of $300,000 for its NightHunter high-intensity illumination devices. The order was received from Aardvark Tactical, Inc. (ATI), Azusa, California, on behalf of the U.S. Marine Corps.

In March 2015, Xenonics announced that it was awarded purchase orders valued at $450,000 for its NightHunter high-intensity illumination devices and accessories. These orders were received from ADS, Inc., Virginia Beach, Virginia, and the Defense Logistics Agency (DLA) on behalf of the U.S. Army.

The NightHunter® is the world’s longest-range and most versatile compact illumination system that allows a user to see more than a mile away. The NightHunter® can be used on foot, from vehicles, boats, and helicopters or fixed mounted.

Xenonics Holdings, Inc. (XNNH), closed Monday's trading session at $0.24, up 61.18%, on 202,802 volume with 28 trades. The average volume for the last 60 days is 28,853 and the stock's 52-week low/high is $0.05/$0.47.

Guided Therapeutics, Inc. (GTHP)

PHUB News, DSR News, TheNextBigTrade, BestDamnPennyStocks, Stock Commander and TopPennyStockMovers reported earlier on Guided Therapeutics, Inc. (GTHP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTC BB-listed Guided Therapeutics, Inc. is the creator of a fast and painless testing platform. This platform is for the early detection of disease based on the Company's patented biophotonic technology, which uses light to detect disease at the cellular level. Its first product is the LuViva® Advanced Cervical Scan. This is a non-invasive device utilized to detect cervical disease immediately and at the point of care. Guided Therapeutics is based in Norcross, Georgia.

The Guided Therapeutics LuViva® Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use. The design of LuViva® is as a quick, painless test that, unlike Pap smears and HPV testing, does not require a tissue sample or the delay of laboratory analysis.

LuViva® is a technologically advanced diagnostic device. It scans the cervix with light and employs spectroscopy to measure how light interacts with the cervical tissue. Spectroscopy identifies chemical and structural indicators of pre-cancer that may be below the surface of the cervix or misdiagnosed as benign. This technique is named biophotonics. Biophotonics is the science of generating and harnessing light to image, detect, and manipulate biological materials.

In a multi-center clinical trial, with women at risk for cervical disease, the LuViva® Advanced Cervical Scan technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. The device is employed in combination with the LuViva® Cervical Guide single-use patient interface and calibration disposable.

The LuViva® Advanced Cervical Scan is now compliant with Edition 2 and Edition 3 CE standards. It has marketing approval from Health Canada and the Singapore Health Sciences Authority. It is under U.S. Food and Drug Administration (FDA) Premarket review. In addition, Guided Therapeutics is developing a non-invasive test for the early detection of esophageal cancer using the technology platform.

Today, Guided Therapeutics announced that it expects to ship 25 LuViva® Advance Cervical Scan units and roughly 40,000 single-patient-use disposables in Q4 of 2015. The shipments are destined for Turkey, Saudi Arabia and Indonesia with manufacturing taking place at the Guided Therapeutics facility in Norcross, Georgia.

Guided Therapeutics, Inc. (GTHP), closed Monday's trading session at $0.0524, up 30.35%, on 4,989,400 volume with 345 trades. The average volume for the last 60 days is 924,787 and the stock's 52-week low/high is $0.0358/$0.35.

Earth Science Tech, Inc. (ETST)

SmallCapVoice, GoldminePennyStocks and Equity Observer reported earlier on Earth Science Tech, Inc. (ETST), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Earth Science Tech, Inc. is a biotechnology company centering on innovative nutraceuticals, bioceuticals, and dietary supplements for the health, nutrition, sports, wellness, and alternative medicine markets. Moreover, it provides natural alternatives to prescription medications through nutritional supplements and dietary supplements. This may include CBD (Cannabidiol) as a natural constituent of hemp oil, vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products.

Earth Science Tech’s aim is to be the foremost supplier of the highest quality hemp oil enriched with high grade CBD. Its principal goal is to advance different high quality hemp extracts with an extensive profile of Cannabinoids and additional natural molecules found in industrial hemp and to identify their individual properties. Cannabinoids (Cannabidiol/CBD) are natural constituents of the hemp plant. CBD is derived from hemp stalk and seed.

The Company’s high grade CBD rich hemp oil has no fillers, preservatives or additives. It is scientifically formulated, 100 percent natural, and derived from the industrial hemp plant with less than .03 percent THC. It is legal and available to ship to all 50 states and more than 40 countries.

Along with CBD, Earth Science Tech’s products include ProgesteBeauty™. This is an anti-aging product scientifically formulated to help balance menopause and perimenopause. Its products also include OxyBiotic™. This is a scientifically formulated oxygen based colon cleanser enhanced with 9 billion live cells of probiotic at the time of manufacturing.

Last month, Earth Science Tech announced its formation of a new wholly-owned subsidiary Earth Science Tech Bioceuticals, Inc. and simultaneously elected Mr. Joseph Pavlik as President.  Earth Science Tech Bioceuticals will be developing, bringing to market, as well as merchandising several inventive products and brands featuring the Earth Science Tech High Grade Hemp CBD Oil. Some of these new products include a novel micronized spray series and an advanced active lifestyle nutrition series featuring ultra-premium hemp based formulations.

Last week, Earth Science Tech announced its genesis in introducing its line of Nutraceutical and Bioceutical products to former/retired professional athletes. The Company is conducting a trial study using its High Grade Hemp CBD Oil with a test group of former/retired professional football players.

Earth Science Tech, Inc. (ETST), closed Monday's trading session at $1.05, up 7.14%, on 51,461 volume with 110 trades. The average volume for the last 60 days is 2,882 and the stock's 52-week low/high is $0.5801/$3.50.

graphic

The QualityStocks
Company Corner

graphic
graphic

Elephant Talk Communications Corp. (ETAK)

The QualityStocks Daily Newsletter would like to spotlight Elephant Talk Communications Corp. (ETAK). Today, Elephant Talk Communications Corp. closed trading at $0.49, even for the day, on 89,944 volume with 67 trades. The stock’s average daily volume over the past 60 days is 102,144, and its 52-week low/high is $0.205/$1.139.

Elephant Talk Communications Corp. (ETAK) provides mobile proprietary Software Defined Network Architecture (ET Software DNA® 2.0) platforms for its growing base of strategic partners and clients, which includes some of today's world-leading MNOs and technology companies, including Vodafone, T-Mobile, Zain, HP and Affirmed Networks.

Targeting its share of the broader $1.4+ trillion telecommunications market, Elephant Talk empowers MNOs, MVNOs, MVNEs and MVNAs with a full suite of applications, reliable industry expertise, and high quality customer service. Understanding that partnership is crucial in enabling and delivering the highest level of quality of product capability and professionalism, Elephant Talk also closely collaborates with other expert organizations and leading service providers.

ValidSoft UK Ltd., a subsidiary of Elephant Talk uses personal authentication and device assurance to secure transactions and help customers reduce fraud losses. As part of its multi-factor authentication, ValidSoft integrates its leading Voice Biometric engine into multivendor solutions or as a standalone system. ValidSoft serves multiple clients in the financial government and business automation sectors and is the only company to have been granted four European Privacy Seals, reflecting its commitment to promoting strong data privacy.

Elephant Talk has implemented rigid structures and processes to ensure corporate integrity and the responsible oversight of all business activities. This vision starts with executive management and extends to every employee. Elephant Talk is guided by a visionary leadership team with a rich history of success in key markets pertinent to both the company's current and desired market positions. In order to achieve and maintain world-class system performance, Elephant Talk leverages this management team along with collaborations with the world's best technical partners. Disclaimer

Elephant Talk Communications Corp. Company Blog

Elephant Talk Communications Corp. News:

Elephant Talk Communications Selected as a MVNO Platform Solution Provider by A Tier 1 US Mobile Operator

Elephant Talk Communications Retains Dawson James Securities as Advisor to Evaluate Strategic Options for ValidSoft UK Ltd.

Elephant Talk Communications Announces Chairman and CEO Roles to be Separated and Addition to the Board of Directors

Hemp, Inc. (HEMP)

The QualityStocks Daily Newsletter would like to spotlight Hemp, Inc. (HEMP). Today, Hemp, Inc. closed trading at $0.06, up 3.45%, on 1,673,390 volume with 120 trades. The stock’s average daily volume over the past 60 days is 1,527,322, and its 52-week low/high is $0.039/$1.00.

Hemp, Inc. announced, today, the release of its quarterly industry publication, The Hemp Nation Magazine (HNM). The 6th "fall/holiday game changing edition" is expected to grab the attention of hemp industry advocates and supporters, as this issue focuses on the rise, fall and resurrection of the hemp industry in America. The online, digital news source is designed to inform, educate, raise awareness and connect the public to the industrial hemp industry by reporting on Politics, Industrial Growth, Banking, Distribution, Medical, Lifestyles and Legalization.

Hemp, Inc. (HEMP) is engaged in the research and development of all things made of industrial hemp. From fabric, paper, cosmetics, food and jewelry to pulp, fuel, paints and more, the application of hemp represents a myriad of possibilities. The company strategizes to recognize the profits that could be made in making the world a better place through the industrial commercialization of this resource.

Hemp, Inc. subsidiaries include Industrial Hemp Manufacturing, LLC, which will soon be offering DrillWall™ for maintaining the seals on drilling for water, oil, gas and any other liquid or gas; and The Industrial Hemp and Medical Marijuana Consulting Company, Inc., which pulls pertinent market information from a vast network of professionals, specialists and experts from various niches of the hemp industry.

Las Vegas-based Hemp, Inc. conducts its operations through its 70,000-square-foot processing plant and decortication line of equipment, which is useful manufacturing more than 50,000 commercial products. The company's current line of offerings include hemp-infused body candles, shampoo and conditioner, smoothies, jewelry, healing oils, twine, lip balm and skin moisturizers.

Hemp products are used all over America every day and are sold in the largest and most respected stores. Not to be confused with marijuana, hemp does not contain psychoactive compounds and is legal in the United States and most of the world. Hemp, Inc.'s mission is to educate the public on this important differentiation while working to expand corporate infrastructure and invest in profitable, legal and diversified ventures poised to bring reward and value to shareholders. Disclaimer

Hemp, Inc. Company Blog

Hemp, Inc. News:

Hemp, Inc. Releases Its 2015, 4th Quarter Hemp Nation Magazine

Hemp, Inc. Reports on Hemp Industry News

Hemp, Inc. Industry Update: House Bill 967 Unanimously Approved by Pennsylvania House Agriculture and Rural Affairs Committee

Oakridge Global Energy Solutions, Inc. (OGES)

The QualityStocks Daily Newsletter would like to spotlight Oakridge Global Energy Solutions, Inc. (OGES). Today, On the Move Systems, Inc. closed trading at $1.38, off by 4.17%, on 17,454 volume with 32 trades. The stock’s average daily volume over the past 90 days is 9,419, and its 52-week low/high is $0.15/$2.40.

Oakridge Global Energy Solutions, Inc. MissionIR today announces the online availability of its interview with OGES Chief Executive Officer Steve Barber.

The full audio interview is available at http://OGES.MissionIR.com/interview.html

Oakridge Global Energy Solutions, Inc. (OGES) specializes in the development of cutting-edge technology to transform and synchronize freight supply chain operations for a broad range of industries. The company is exploring new online tools to reduce costs and increase convenience in the tourism and travel industry, as well as new opportunities in trucking. OMVS works with a premier group of international providers to offer its services in two key divisions: Trucking Logistics and Inter-modal Freight.

Logistics are critical to the success of any operation. OMVS's Trucking Logistics division operates as one of the most competitive, full-service transportation logistics providers in the United States. Utilizing the company's ISTx Platform, this division helps customers strategize how to get from one point to another, as well as solves some of the toughest logistics challenges on the road today. OMVS's Trucking Logistics technology provides customers increased visibility, minimal-cost route effectiveness, and delivery assurance.

OMVS's Intermodal Freight division offers seamless cargo continuation, tracking, shipping and receiving of goods anywhere in the world. The company's customer service teams and drivers communicate through the ISTx Platform allowing for flexibility, control and monitoring of each freight shipment. OMVS continues to research and explore the most effective and resourceful tools in order to effectively serve customers with unique shipping requirements in the billion dollar trucking industry.

In his more than 20 years of experience, OMVS president and CEO Robert Wilson has cultivated vast expertise as an executive and financial consultant for companies in aviation, energy, oil and gas, IT and healthcare. In addition to his work valuing and assessing small-to-middle market companies, Wilson has also served as both an officer and director of such client companies. Wilson applies his expertise in the transportation business and investment banking to spearhead OMVS's new initiative to create a new kind of online transportation platform to an international market Disclaimer

Oakridge Global Energy Solutions, Inc. Company Blog

Oakridge Global Energy Solutions, Inc. News:

MissionIR Exclusive Audio Interview With Oakridge Global Energy Solutions, Inc. (OGES) CEO Steve Barber

Oakridge Global Energy Solutions Announces Plans to Produce Commercial Thin Film Solid State Lithium Batteries

Florida Governor Recognizes OGES for Ushering in New Era in Battery Manufacturing, Creating Local Jobs

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $5.70, up 44.67%, on 103,733 volume with 334 trades. The stock’s average daily volume over the past 90 days is 6,035, and its 52-week low/high is $1.25/$18.15.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

International Stem Cell Corporation Presents Comprehensive Findings for Parkinson's Disease Program Preclinical Studies at the Society for Neuroscience Annual Meeting, Neuroscience 2015

International Stem Cell Corporation Develops Technology to Replace Cartilage for the Treatment of Osteoarthritis

International Stem Cell Names Ms. Ebrahimi as Chief Financial Officer

Giggles N' Hugs, Inc. (GIGL)

The QualityStocks Daily Newsletter would like to spotlight Giggles N' Hugs, Inc. (GIGL). Today, Giggles N' Hugs, Inc. closed trading at $0.17995, up 19.73%, on 4,613 volume with 4 trades. The stock’s average daily volume over the past 60 days is 26,965, and its 52-week low/high is $0.101/$0.55.

Los Angeles-based Giggles N' Hugs, Inc. (GIGL) is a first-of-its-kind, award-winning family restaurant and play space that combines organic gourmet food with the play elements for children in a 2500-square-foot play space in the middle of the restaurant. The concept is similar to Chuck E. Cheese, but offers a unique healthier, high-end version for health conscious parents and families. Parents eat and relax while the kids have an incredible time playing in the custom-made play area with giant climbers, dragons, castles, pirate ships slides and swings and a multitude of other toys.

In addition to nightly shows and concerts, every 30 minutes Giggles N' Hugs provides an activity such as face painting, disco dance parties, karaoke, games, arts and crafts, and much more. Giggles N' Hugs has been voted the No. 1 family restaurant, No. 1 birthday party place, and the No. 1 indoor play space in all of Los Angeles, and has attracted a star-studded list of customers including Sandra Bullock, Heidi Klum, Jessica Alba, Halle Berry, Jennifer Garner and Ben Affleck, Denis Quaid, Mark Whalberg, Adam Sandler, Dustin Hoffman and many more.

Revenue is derived from several sources, including food and beverage sales, beer and wine, birthday parties (40%), admission and membership fees to play, along with retail sales. These revenue-generating locations are also highly sought-after tenants. The company currently has three locations in the top premier malls around Los Angeles; four of the largest mall owners in the country are giving Giggles N' Hugs up to 75% discounts on rent and providing upward of $700,000 of upfront cash for each location to get Giggles N' Hugs into their malls around the country.

Growth and recognition of this caliber are driven by a very powerful management team. Giggles N' Hugs President John Kaufman was the COO at California Pizza Kitchen when the founders had just two locations. Joined by Giggles N' Hugs' CFO Phillip Gay, who at the time was CFO of California Kitchen, Kaufman grew the company from two to more than 100 locations – at which time it was bought by Pepsi Co. Kaufman was recruited as president of Koo Koo Roo Chicken, one of the fastest growing fast-casual concepts on the west coast, while Gay joined Wolfgang Puck Restaurants group as CFO, eventually becoming the CEO.

Giggles N' Hugs was founded as a truly "kid friendly" establishment catered specifically to the size, interests, and nutrition needs of children. Since opening its first Giggles N' Hugs in 2009, the company has received a steady stream of interest from more than 300 interested parties looking to expand the concept – via franchise or master licenses – in the U.S. as well globally in countries such as Germany, England, Dubai, Russia, Colombia, Australia , Singapore, Turkey, among the many more. Disclaimer

Giggles N' Hugs, Inc. Company Blog

Giggles N' Hugs, Inc. News:

Giggles Ní Hugs Announces Second Quarter 2015 Financial Results

Giggles Ní Hugs Advances Negotiations with largest National Mall Owners

Interest in Giggles Ní Hugs Franchise Opportunities Continues to Grow

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

QualityStocks
(OVTZ)

2.

Epic Stock Picks
(RLIA)

3.

Tip.us
(ISCO)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251